The possible role of enterothepatic cycling on bioavailibility of noretisterone and gestodene in women using combined oral contraceptives (HTML)
Elomaa,Kaisa; Ranta,Sirpa; Tuominen,Juhani; Lahteenmaki,Pekka
Contraception 63(1): 13-18
Publication date: 2001
Using steady-state conditions we aimed to test if administration of oral activated charcoal affects the bioavailability of norethisterone acetate (NET Ac) and gestodene (GEST) by inhibiting their enterohepatic recirculation. Thirteen volunteers received, in a randomized order, Minulet® (75 µg GEST and 30 µg ethinylestradiol [EE2]) and Econ/30® (1 mg NET Ac and 30 µg EE2), each for 4 months. Serum GEST and norethisterone (NET) levels were evaluated with respect to Cmax, tmax and 24-h area under the curve (AUC0-24h) in the middle of the control (3rd) cycle and the charcoal treatment (4th) cycle during both pill treatments. No statistically significant difference was seen in any of the aforementioned variables between the control and charcoal treatment cycles of either pill. Neither was a difference seen in the bioavailability of GEST and NET as evaluated by the ratios of two 24-h AUCs calculated in the control and charcoal cycles of each pill treatment (p = 0.29). The results suggest that enterohepatic circulation of GEST and NET is not of clinical importance. We conclude that women on oral contraceptives can take activated charcoal for the treatment of diarrhea when administered 3 h after and at least 12 h before pill intake.
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.